FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * FELDER MITCHELL S 2. Issuer Name and Ticker or Trading Symbol PREMIER BIOMEDICAL INC [ BIEI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chairman of the Board
(Last)         (First)         (Middle)
P.O. BOX 25
3. Date of Earliest Transaction (MM/DD/YYYY)
9/11/2019
(Street)
JACKSON CENTER, PA 16133
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/11/2019    P    300000  A $0.008  1628031  D   
Common Stock  9/11/2019    P    100000  A $0.0082  1728031  D   
Common Stock  9/11/2019    P    250000  A $0.0082  1978031  D   
Common Stock  9/11/2019    P    30250  A $0.0082  2008281  D   
Common Stock  9/11/2019    P    1207  A $0.0085  2009488  D   
Common Stock  9/11/2019    P    100000  A $0.009  2109488  D   
Common Stock  9/11/2019    P    156892  A $0.0095  2266380  D   
Common Stock  9/11/2019    P    40000  A $0.0095  2306380  D   
Common Stock  9/11/2019    P    28108  A $0.0095  2334488  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
FELDER MITCHELL S
P.O. BOX 25
JACKSON CENTER, PA 16133
X X Chairman of the Board

Signatures
/s/ Dr. Mitchell S. Felder 9/11/2019
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more Premier Biomedical (PK) Charts.
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more Premier Biomedical (PK) Charts.